| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009516804 |
| P356 | DOI | 10.1007/S00281-014-0425-9 |
| P698 | PubMed publication ID | 24777744 |
| P5875 | ResearchGate publication ID | 261956356 |
| P50 | author | Gerd Wallukat | Q63288594 |
| Ingolf Schimke | Q56959779 | ||
| P2860 | cites work | Autoantibodies against G-protein-coupled receptors modulate heart mast cells | Q80278334 |
| Autoantibodies against the serotoninergic 5-HT4 receptor and congenital heart block: a reassessment | Q80357088 | ||
| Beta 1-adrenergic receptor autoantibodies mediate dilated cardiomyopathy by agonistically inducing cardiomyocyte apoptosis | Q80589402 | ||
| A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure | Q80698999 | ||
| Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy | Q81051500 | ||
| Immunoadsorption in idiopathic dilated cardiomyopathy, a 3-year follow-up | Q81051503 | ||
| Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors | Q84289582 | ||
| Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies | Q84400365 | ||
| Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA | Q84587744 | ||
| The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies | Q84690306 | ||
| Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parameters | Q84962464 | ||
| Role of anti-β1 adrenergic antibodies from patients with periodontitis in cardiac dysfunction | Q85014063 | ||
| Targeting anti-beta-1-adrenergic receptor antibodies for dilated cardiomyopathy | Q27000434 | ||
| Autoantibodies against muscarinic type 3 receptor in Sjögren's syndrome inhibit aquaporin 5 trafficking | Q27323059 | ||
| Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension | Q28575913 | ||
| Reduced oxidative stress in parallel to improved cardiac performance one year after selective removal of anti-beta 1-adrenoreceptor autoantibodies in patients with idiopathic dilated cardiomyopathy: data of a preliminary study | Q30989751 | ||
| Autoantibodies to muscarinic acetylcholine receptors found in patients with primary biliary cirrhosis | Q33720002 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Ligand-specific conformation of extracellular loop-2 in the angiotensin II type 1 receptor | Q33855316 | ||
| Agonist-induced increase in apparent β-adrenergic receptor size | Q33955321 | ||
| Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy | Q33974796 | ||
| Toxicological evaluation of oligonucleotide therapeutics | Q34182586 | ||
| Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism | Q34244290 | ||
| Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography | Q34364148 | ||
| Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. | Q34491578 | ||
| Molecular mechanisms of anti-G-protein-coupled receptor autoantibodies | Q34574047 | ||
| Autoantibodies against muscarinic receptors in breast cancer: their role in tumor angiogenesis | Q34608685 | ||
| Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy | Q34646571 | ||
| Receptor-activating autoantibodies and disease: preeclampsia and beyond | Q35707881 | ||
| Location and nature of the residues important for ligand recognition in G-protein coupled receptors | Q35896272 | ||
| Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. | Q36548874 | ||
| Identification of antibodies with muscarinic cholinergic activity in human Chagas' disease: pathological implications | Q58843978 | ||
| Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon: their potential impact for early risk assessment in asymptomatic Chagas' patients | Q58844042 | ||
| A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity | Q58846968 | ||
| Autoantibodies against the beta-adrenergic receptor in human myocarditis and dilated cardiomyopathy: beta-adrenergic agonism without desensitization | Q67700979 | ||
| Autoantibodies to β-adrenergic receptors with antiadrenergic activity from patients with allergic asthma | Q68257393 | ||
| Influence of anti-beta-receptor antibodies on cardiac adenylate cyclase in patients with idiopathic dilated cardiomyopathy | Q68463587 | ||
| Dilated cardiomyopathy defines serum autoantibodies against G-protein-coupled cardiovascular receptors | Q71186954 | ||
| Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension | Q71662795 | ||
| Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops | Q71694608 | ||
| High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities | Q71745703 | ||
| Agonistic effects of anti-peptide antibodies and autoantibodies directed against adrenergic and cholinergic receptors: absence of desensitization | Q71917946 | ||
| Activation of cyclic AMP-dependent protein kinase in cardiomyocytes by anti-beta 1-adrenoceptor autoantibodies from patients with idiopathic dilated cardiomyopathy | Q71917952 | ||
| Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies | Q73069755 | ||
| Alpha 1-adrenergic receptor antibodies in patients with primary hypertension | Q73089177 | ||
| Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block | Q73166166 | ||
| Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy | Q73303001 | ||
| Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy | Q73470133 | ||
| Autoantibodies against the second extracellular loop of beta1-adrenergic receptors predict ventricular tachycardia and sudden death in patients with idiopathic dilated cardiomyopathy | Q73536358 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits | Q74031533 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor | Q74267890 | ||
| Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects | Q74589807 | ||
| Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy | Q78587830 | ||
| Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy | Q80192209 | ||
| Are Agonistic Autoantibodies against G-Protein Coupled Receptors Involved in the Development of Long-Term Side Effects of Tumor Chemotherapy? | Q36744349 | ||
| Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment | Q38027725 | ||
| Immunoadsorption therapy for dilated cardiomyopathy and pulmonary arterial hypertension | Q38077335 | ||
| Activating autoantibodies and cardiovascular disease | Q38118625 | ||
| Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia | Q39409827 | ||
| Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies | Q39714169 | ||
| Autoimmunity against the β2 adrenergic receptor and muscarinic-2 receptor in complex regional pain syndrome | Q39721007 | ||
| Immunoglobulin G from breast cancer patients in stage I stimulates muscarinic acetylcholine receptors in MCF7 cells and induces proliferation. Participation of nitric oxide synthase-derived nitric oxide. | Q39739073 | ||
| Effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy. | Q39839980 | ||
| Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression | Q40266096 | ||
| Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy | Q40841949 | ||
| Autoantibodies to β2-Adrenergic Receptors: a Possible Cause of Adrenergic Hyporesponsiveness in Allergic Rhinitis and Asthma | Q40862381 | ||
| Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy | Q41108919 | ||
| Antiadrenergic and muscarinic receptor antibodies in Chagas' cardiomyopathy | Q41108938 | ||
| Removal of autoantibodies in dilated cardiomyopathy by immunoadsorption | Q41108977 | ||
| Anti-peptide antibodies sensitive to the 'active' state of the beta2-adrenergic receptor | Q41145655 | ||
| A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. | Q41186190 | ||
| In vitro effects of reactive O2 species on the β-receptor-adenylyl cyclase system | Q42451088 | ||
| Agonistic antibody to the alpha1-adrenergic receptor mobilizes intracellular calcium and induces phosphorylation of a cardiac 15-kDa protein | Q43291018 | ||
| Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy | Q43626109 | ||
| Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes | Q43670106 | ||
| Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption | Q43672370 | ||
| Anti-β-adrenoceptors autoimmunity causing 'idiopathic' arrhythmias and cardiomyopathy | Q43835988 | ||
| Therapeutic use of muscarinic acetylcholine receptor peptide to prevent mice chagasic cardiac dysfunction | Q44264613 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells | Q44320558 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes | Q44392529 | ||
| Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chronotropic beta adrenoceptor function in cultured neonatal rat heart myocytes | Q44657870 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Antibodies to beta 1 and beta 2 adrenoreceptors in Chagas' disease | Q46161530 | ||
| From agonist to antagonist: Fab fragments of an agonist-like monoclonal anti-beta(2)-adrenoceptor antibody behave as antagonists | Q46208108 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients. | Q46653992 | ||
| Effect of chagasic sera on the rat isolated atrial preparation: immunological, morphological and function aspects | Q46790587 | ||
| Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice | Q47211148 | ||
| Agonistic AT1 receptor autoantibodies and monocyte stimulation in hypertensive patients*1 | Q47447775 | ||
| Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies | Q47630949 | ||
| Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure | Q48186336 | ||
| Ig apheresis for the treatment of severe DCM patients | Q48309211 | ||
| Economic evaluation and survival analysis of immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. | Q50749673 | ||
| Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. | Q50957107 | ||
| Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy. | Q51772854 | ||
| Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease. | Q51798355 | ||
| Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy. | Q52887237 | ||
| Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. | Q52900457 | ||
| Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. | Q52905846 | ||
| Agonistic anti-beta1-adrenergic receptor autoantibodies from cardiomyopathy patients reduce the beta1-adrenergic receptor expression in neonatal rat cardiomyocytes. | Q52991955 | ||
| Autoantibodies in Sjögren's syndrome patients acutely inhibit muscarinic receptor function. | Q53407460 | ||
| Pro-apoptotic effect of anti-β1-adrenergic receptor antibodies in periodontitis patients. | Q54474836 | ||
| Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications | Q58843227 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| autoantibody | Q785022 | ||
| G protein-coupled receptor | Q38173 | ||
| P304 | page(s) | 351-363 | |
| P577 | publication date | 2014-04-29 | |
| P1433 | published in | Seminars in Immunopathology | Q15724576 |
| P1476 | title | Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases | |
| P478 | volume | 36 |
| Q90723443 | A Three-Part, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Mode of Action of BC 007, Neutraliser of Pathogenic Autoantibodies Against G-Protein Coupled Receptors in Healthy, Young and Elderly Subjects |
| Q36052778 | AT2R autoantibodies block angiotensin II and AT1R autoantibody-induced vasoconstriction |
| Q90235196 | Adrenergic Autoantibody-Induced Postural Tachycardia Syndrome in Rabbits |
| Q90305559 | Angiotensin II Type 1 Receptor Autoantibodies in Primary Aldosteronism |
| Q48924237 | Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia |
| Q99726453 | Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer |
| Q52603631 | Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3. |
| Q60950061 | Beta-1-Adrenergic Receptor Antibodies in Acute Coronary Syndrome: Is Less Sometimes More? |
| Q59333238 | CD8+-T Cells With Specificity for a Model Antigen in Cardiomyocytes Can Become Activated After Transverse Aortic Constriction but Do Not Accelerate Progression to Heart Failure |
| Q40138726 | Cardiac Autoimmunity: Myocarditis. |
| Q52866222 | Complex regional pain syndrome and dysautonomia in a 14-year-old girl responsive to therapeutic plasma exchange. |
| Q39397383 | Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism |
| Q90562248 | Cyclic peptide RD808 reduces myocardial injury induced by β1-adrenoreceptor autoantibodies |
| Q89495747 | Diagnostic and prognostic value of autoantibodies against β1-adrenoreceptors in patients with heart failure following acute myocardial infarction: A 5-year prospective study |
| Q50099198 | Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology |
| Q34585190 | Effect of prazosin on diabetic nephropathy patients with positive α1-adrenergic receptor autoantibodies and refractory hypertension |
| Q43354218 | Effects of long-term active immunization with the second extracellular loop of human β1- or β3-adrenoceptors in thoracic aorta and mesenteric arteries in Lewis rats. |
| Q52807608 | Functional autoantibodies in patients with different forms of dementia. |
| Q38570322 | Functional autoantibodies in systemic sclerosis |
| Q52807496 | Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. |
| Q37682101 | Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema |
| Q90641212 | Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndrome |
| Q41223452 | Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy |
| Q39342382 | Role of the Immune System in Hypertension |
| Q35999775 | Structure-Function Basis of Attenuated Inverse Agonism of Angiotensin II Type 1 Receptor Blockers for Active-State Angiotensin II Type 1 Receptor |
| Q47166753 | T helper cells with specificity for an antigen in cardiomyocytes promote pressure overload-induced progression from hypertrophy to heart failure |
| Q37206448 | The Prognostic Role of Angiotensin II Type 1 Receptor Autoantibody in Non-Gravid Hypertension and Pre-eclampsia: A Meta-analysis and Our Studies |
| Q90649800 | The aptamer BC 007 for treatment of dilated cardiomyopathy: evaluation in Doberman Pinschers of efficacy and outcomes |
| Q50096185 | The mechanisms behind decreased internalization of angiotensin II type 1 receptor |
| Q88147703 | The non-biphenyl-tetrazole angiotensin AT1 receptor antagonist eprosartan is a unique and robust inverse agonist of the active state of the AT1 receptor |
| Q37240779 | Transglutaminase is a Critical Link Between Inflammation and Hypertension |
| Q95282452 | Unmasking features of the auto-epitope essential for β1 -adrenoceptor activation by autoantibodies in chronic heart failure |
Search more.